L. Jávor

Dynamic Contrast-Enhanced MRI Parameters as Biomarkers in Assessing Head and Neck Lesions After Chemoradiotherapy Using a Wide-Bore 3 Tesla Scanner

Z. Takácsi-Nagy, L. Tamás, A. Boér, 2015, Pathology & Oncology Research.

Correlation of GAA Genotype and Acid-α-Glucosidase Enzyme Activity in Hungarian Patients with Pompe Disease

L. Kerényi, Z. Almássy, M. Molnár, 2021, Life.

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.

D. Tanné, D. Blacker, S. Connolly, 2018, The Lancet. Neurology.

[The long-term follow-up of enzyme replacement treatment in late onset Pompe disease].

L. Kerényi, Z. Almássy, L. Dézsi, 2020, Ideggyogyaszati szemle.